Margherita Mastromarino

Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors

Mariagrazia Rullo, Gabriella La Spada, Daniela Valeria Miniero et al. · European Journal of Medicinal Chemistry · 2023 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Enhanced Plasma Availability of the Metabolites of Albendazole in Fasted Adult Sheep

A. Lifschitz, G. Virkel, Margherita Mastromarino et al. · Veterinary Research Communications · 1997 · 27 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +9

The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Improves Ex Vivo and In Vivo Amyloid Beta (1–42)-Induced Neuroinflammation in Mouse Models of Alzheimer’s Disease

Ewa Trojan, Kinga Tylek, Nicole Schröder et al. · Molecular Neurobiology · 2021 · 26 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder

Enza Lacivita, Mauro Niso, Margherita Mastromarino et al. · ACS Chemical Neuroscience · 2021 · 20 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders

Margherita Mastromarino, Maria Favia, Igor A. Schepetkin et al. · Journal of Medicinal Chemistry · 2022 · 14 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17